In cancer research, the Nrf2 antioxidant signaling pathway has been shown to be involved in the protection of hepatocellular carcinoma cells from ferroptosis by regulating the expression of FTH1 but not TFR1 [26]. Here, TFRC is linked to hepatocellular carcinoma.